Munck A - Search Results

1

Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization.

Hubert D, Marguet C, Benichou J, DeSouza C, Payen-Champenois C, Kinnman N, Chandarana K, Munck A, Fajac I; BRIO Study Group. Hubert D, et al. Among authors: munck a. Pulm Ther. 2021 Dec;7(2):455-468. doi: 10.1007/s41030-021-00158-5. Epub 2021 Jun 8. Pulm Ther. 2021. PMID: 34101145 Free PMC article.

2

Correction to: Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization.

Hubert D, Marguet C, Benichou J, DeSouza C, Payen-Champenois C, Kinnman N, Chandarana K, Munck A, Fajac I; BRIO Study Group. Hubert D, et al. Among authors: munck a. Pulm Ther. 2021 Dec;7(2):469-470. doi: 10.1007/s41030-021-00165-6. Pulm Ther. 2021. PMID: 34260039 Free PMC article. No abstract available.

3

Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2years of treatment with ivacaftor in a real-world setting.

Hubert D, Dehillotte C, Munck A, David V, Baek J, Mely L, Dominique S, Ramel S, Danner Boucher I, Lefeuvre S, Reynaud Q, Colomb-Jung V, Bakouboula P, Lemonnier L. Hubert D, et al. Among authors: munck a. J Cyst Fibros. 2018 Jan;17(1):89-95. doi: 10.1016/j.jcf.2017.07.001. Epub 2017 Jul 12. J Cyst Fibros. 2018. PMID: 28711222 Free article.

4

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

Burgel PR, Munck A, Durieu I, Chiron R, Mely L, Prevotat A, Murris-Espin M, Porzio M, Abely M, Reix P, Marguet C, Macey J, Sermet-Gaudelus I, Corvol H, Bui S, Lemonnier L, Dehillotte C, Da Silva J, Paillasseur JL, Hubert D; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Among authors: munck a. Am J Respir Crit Care Med. 2020 Jan 15;201(2):188-197. doi: 10.1164/rccm.201906-1227OC. Am J Respir Crit Care Med. 2020. PMID: 31601120

5

Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function.

Burgel PR, Durieu I, Chiron R, Mely L, Prevotat A, Murris-Espin M, Porzio M, Abely M, Reix P, Marguet C, Macey J, Sermet-Gaudelus I, Corvol H, Bui S, Biouhee T, Hubert D, Munck A, Lemonnier L, Dehillotte C, Silva JD, Paillasseur JL, Martin C; French Cystic Fibrosis Reference Network study group. Burgel PR, et al. Among authors: munck a. J Cyst Fibros. 2021 Mar;20(2):220-227. doi: 10.1016/j.jcf.2020.06.012. Epub 2020 Jun 24. J Cyst Fibros. 2021. PMID: 32591294 Free article.

6

[New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein].

Hubert D, Bui S, Marguet C, Colomb-Jung V, Murris-Espin M, Corvol H, Munck A. Hubert D, et al. Among authors: munck a. Rev Mal Respir. 2016 Oct;33(8):658-665. doi: 10.1016/j.rmr.2015.11.010. Epub 2016 Jan 21. Rev Mal Respir. 2016. PMID: 26806675 Review. French.

7

AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis.

Beucher J, Boëlle PY, Busson PF, Muselet-Charlier C, Clement A, Corvol H; French C F Modifier Gene Study Investigators. Beucher J, et al. PLoS One. 2012;7(7):e41913. doi: 10.1371/journal.pone.0041913. Epub 2012 Jul 30. PLoS One. 2012. PMID: 22860029 Free PMC article.

8

Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!

Martin C, Hamard C, Kanaan R, Boussaud V, Grenet D, Abély M, Hubert D, Munck A, Lemonnier L, Burgel PR. Martin C, et al. Among authors: munck a. J Cyst Fibros. 2016 Mar;15(2):204-12. doi: 10.1016/j.jcf.2015.09.002. Epub 2015 Sep 26. J Cyst Fibros. 2016. PMID: 26391389 Free article.

9

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis.

Boëlle PY, Viviani L, Busson PF, Olesen HV, Ravilly S, Stern M, Assael BM, Barreto C, Drevinek P, Thomas M, Krivec U, Mei-Zahav M, Vibert JF, Clement A, Mehta A, Corvol H; French CF Modifier Gene Study Investigators; European CF Registry Working Group. Boëlle PY, et al. Orphanet J Rare Dis. 2012 Sep 7;7:64. doi: 10.1186/1750-1172-7-64. Orphanet J Rare Dis. 2012. PMID: 22958330 Free PMC article.

10

Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective study.

Munck A, Kheniche A, Alberti C, Hubert D, Martine RG, Nove-Josserand R, Pin I, Bremont F, Chiron R, Couderc L, Dalphin ML, Darviot E, Delaisi B, Dominique S, Durieu I, Fanton A, Fayon M, Gérardin M, Giniès JL, Giraut C, Grenet D, Guillot M, Huet F, Le Bourgeois M, Murris-Epin M, Ramel S, Sardet A, Sermet-Gaudelus I, Varaigne F, Wanin S, Weiss L, Hurtaud MF. Munck A, et al. J Cyst Fibros. 2015 Jan;14(1):97-103. doi: 10.1016/j.jcf.2014.05.015. Epub 2014 Aug 5. J Cyst Fibros. 2015. PMID: 25107684 Free article.

11

[New therapeutic developments in cystic fibrosis].

Bui S, Macey J, Fayon M; « nouvelles thérapeutiques de la Société Française pour la Mucoviscidose »; Bihouée T, Burgel PR, Colomb V, Corvol H, Durieu I, Hubert D, Marguet C, Mas E, Munck A, Murris-Espin M, Reix P, Sermet-Gaudelus I. Bui S, et al. Among authors: munck a. Arch Pediatr. 2016 Dec;23(12S):12S47-12S53. doi: 10.1016/S0929-693X(17)30062-3. Arch Pediatr. 2016. PMID: 28231894 Review. French.

12

[Digestive complications in adults with cystic fibrosis].

Dray X, Hubert D, Munck A, Moreau J, Marteau P. Dray X, et al. Among authors: munck a. Gastroenterol Clin Biol. 2005 Dec;29(12):1279-85. doi: 10.1016/s0399-8320(05)82222-5. Gastroenterol Clin Biol. 2005. PMID: 16518288 Free article. Review. French.

13

[Malnutrition and low bone mineralisation in adults with cystic fibrosis].

Dray X, Hubert D, Munck A, Cormier C, Moreau J, Marteau P. Dray X, et al. Among authors: munck a. Gastroenterol Clin Biol. 2006 Nov;30(11):1257-64. Gastroenterol Clin Biol. 2006. PMID: 17193731 Review. French.

14

Pancreatic enzyme replacement therapy for young cystic fibrosis patients.

Munck A, Duhamel JF, Lamireau T, Le Luyer B, Le Tallec C, Bellon G, Roussey M, Foucaud P, Giniès JL, Houzel A, Marguet C, Guillot M, David V, Kapel N, Dyard F, Henniges F. Munck A, et al. J Cyst Fibros. 2009 Jan;8(1):14-8. doi: 10.1016/j.jcf.2008.07.003. Epub 2008 Aug 21. J Cyst Fibros. 2009. PMID: 18718819 Free article. Clinical Trial.

15

Reclassifying inconclusive diagnosis for cystic fibrosis with new generation sweat test.

Nguyen-Khoa T, Hatton A, Drummond D, Aoust L, Schlatter J, Martin C, Ramel S, Kiefer S, Gachelin E, Stremler N, Cosson L, Gabsi A, Remus N, Benhamida M, Hadchouel A, Fajac I, Munck A, Girodon E, Sermet-Gaudelus I. Nguyen-Khoa T, et al. Among authors: munck a. Eur Respir J. 2022 Aug 4;60(2):2200209. doi: 10.1183/13993003.00209-2022. Print 2022 Aug. Eur Respir J. 2022. PMID: 35777769 Free article. No abstract available.

16

Erratum à l'article « Nouvelles thérapeutiques de la mucoviscidose ciblant le gène ou la protéine CFTR » [Rev. Mal. Respir. (2016). doi: 10.1016/j.rmr.2015.11.010].

Hubert D, Bui S, Marguet C, Colomb-Jung V, Murris-Espin M, Corvol H, Munck A. Hubert D, et al. Among authors: munck a. Rev Mal Respir. 2016 Jun;33(6):558. doi: 10.1016/j.rmr.2016.02.005. Epub 2016 Apr 23. Rev Mal Respir. 2016. PMID: 27117927 French. No abstract available.

17

Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.

Roux AL, Catherinot E, Soismier N, Heym B, Bellis G, Lemonnier L, Chiron R, Fauroux B, Le Bourgeois M, Munck A, Pin I, Sermet I, Gutierrez C, Véziris N, Jarlier V, Cambau E, Herrmann JL, Guillemot D, Gaillard JL; OMA group. Roux AL, et al. Among authors: munck a. J Cyst Fibros. 2015 Jan;14(1):63-9. doi: 10.1016/j.jcf.2014.07.004. Epub 2014 Jul 30. J Cyst Fibros. 2015. PMID: 25085077 Free article.

18

Nutritional Status in the First 2 Years of Life in Cystic Fibrosis Diagnosed by Newborn Screening.

Munck A, Boulkedid R, Weiss L, Foucaud P, Wizla-Derambure N, Reix P, Bremont F, Derelle J, Schroedt J, Alberti C; Gastroenterology and Nutrition Société française de la Mucoviscidose (SFM) Working Group and the ALIMUDE Study Group. Munck A, et al. J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):123-130. doi: 10.1097/MPG.0000000000001956. J Pediatr Gastroenterol Nutr. 2018. PMID: 29543697

19

Management of pancreatic, gastrointestinal and liver complications in adult cystic fibrosis.

Munck A, Languepin J, Debray D, Lamireau T, Abely M, Huet F, Maudinas R, Michaud L, Mas E. Munck A, et al. Rev Mal Respir. 2015 Jun;32(6):566-85. doi: 10.1016/j.rmr.2014.12.008. Epub 2015 May 19. Rev Mal Respir. 2015. PMID: 26001957 Review.

20

Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.

Sermet-Gaudelus I, Girodon E, Roussel D, Deneuville E, Bui S, Huet F, Guillot M, Aboutaam R, Renouil M, Munck A, des Georges M, Iron A, Thauvin-Robinet C, Fajac I, Lenoir G, Roussey M, Edelman A. Sermet-Gaudelus I, et al. Among authors: munck a. Thorax. 2010 Jun;65(6):539-44. doi: 10.1136/thx.2009.123422. Thorax. 2010. PMID: 20522854

21

Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport.

Sermet-Gaudelus I, Girodon E, Sands D, Stremmler N, Vavrova V, Deneuville E, Reix P, Bui S, Huet F, Lebourgeois M, Munck A, Iron A, Skalicka V, Bienvenu T, Roussel D, Lenoir G, Bellon G, Sarles J, Macek M, Roussey M, Fajac I, Edelman A. Sermet-Gaudelus I, et al. Among authors: munck a. Am J Respir Crit Care Med. 2010 Oct 1;182(7):929-36. doi: 10.1164/rccm.201003-0382OC. Epub 2010 Jun 10. Am J Respir Crit Care Med. 2010. PMID: 20538955

22

Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results.

Bradley JM, Koker P, Deng Q, Moroni-Zentgraf P, Ratjen F, Geller DE, Elborn JS; Tiotropium Cystic Fibrosis Study Group. Bradley JM, et al. PLoS One. 2014 Sep 4;9(9):e106195. doi: 10.1371/journal.pone.0106195. eCollection 2014. PLoS One. 2014. PMID: 25188297 Free PMC article. Clinical Trial.

23

Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST).

McKone EF, Borowitz D, Drevinek P, Griese M, Konstan MW, Wainwright C, Ratjen F, Sermet-Gaudelus I, Plant B, Munck A, Jiang Y, Gilmartin G, Davies JC; VX08-770-105 (PERSIST) Study Group. McKone EF, et al. Among authors: munck a. Lancet Respir Med. 2014 Nov;2(11):902-910. doi: 10.1016/S2213-2600(14)70218-8. Epub 2014 Oct 9. Lancet Respir Med. 2014. PMID: 25311995 Clinical Trial.

24

Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutations.

Munck A, Kerem E, Ellemunter H, Campbell D, Wang LT, Ahluwalia N, Owen CA, Wainwright C. Munck A, et al. J Cyst Fibros. 2020 Nov;19(6):962-968. doi: 10.1016/j.jcf.2020.04.015. Epub 2020 Jun 13. J Cyst Fibros. 2020. PMID: 32546431 Free article. Clinical Trial.

25

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation.

De Boeck K, Munck A, Walker S, Faro A, Hiatt P, Gilmartin G, Higgins M. De Boeck K, et al. Among authors: munck a. J Cyst Fibros. 2014 Dec;13(6):674-80. doi: 10.1016/j.jcf.2014.09.005. Epub 2014 Sep 26. J Cyst Fibros. 2014. PMID: 25266159 Free article. Clinical Trial.

26

Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor.

Borowitz D, Lubarsky B, Wilschanski M, Munck A, Gelfond D, Bodewes F, Schwarzenberg SJ. Borowitz D, et al. Among authors: munck a. Dig Dis Sci. 2016 Jan;61(1):198-207. doi: 10.1007/s10620-015-3834-2. Epub 2015 Aug 7. Dig Dis Sci. 2016. PMID: 26250833 Clinical Trial.

27

Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del.

Taylor-Cousar JL, Munck A, McKone EF, van der Ent CK, Moeller A, Simard C, Wang LT, Ingenito EP, McKee C, Lu Y, Lekstrom-Himes J, Elborn JS. Taylor-Cousar JL, et al. Among authors: munck a. N Engl J Med. 2017 Nov 23;377(21):2013-2023. doi: 10.1056/NEJMoa1709846. Epub 2017 Nov 3. N Engl J Med. 2017. PMID: 29099344 Free article. Clinical Trial.

28

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group; TRANSPORT Study Group. Wainwright CE, et al. Among authors: munck a. N Engl J Med. 2015 Jul 16;373(3):220-31. doi: 10.1056/NEJMoa1409547. Epub 2015 May 17. N Engl J Med. 2015. PMID: 25981758 Free PMC article. Clinical Trial.

29

Cystic fibrosis: evidence for gut inflammation.

Munck A. Munck A. Int J Biochem Cell Biol. 2014 Jul;52:180-3. doi: 10.1016/j.biocel.2014.02.005. Epub 2014 Feb 15. Int J Biochem Cell Biol. 2014. PMID: 24548777 Review.

30

The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening.

Thauvin-Robinet C, Munck A, Huet F, Génin E, Bellis G, Gautier E, Audrézet MP, Férec C, Lalau G, Georges MD, Claustres M, Bienvenu T, Gérard B, Boisseau P, Cabet-Bey F, Feldmann D, Clavel C, Bieth E, Iron A, Simon-Bouy B, Costa C, Medina R, Leclerc J, Hubert D, Nové-Josserand R, Sermet-Gaudelus I, Rault G, Flori J, Leroy S, Wizla N, Bellon G, Haloun A, Perez-Martin S, d'Acremont G, Corvol H, Clément A, Houssin E, Binquet C, Bonithon-Kopp C, Alberti-Boulmé C, Morris MA, Faivre L, Goossens M, Roussey M; Collaborating Working Group on R117H; Girodon E. Thauvin-Robinet C, et al. Among authors: munck a. J Med Genet. 2009 Nov;46(11):752-8. doi: 10.1136/jmg.2009.067215. Epub 2009 Jun 29. J Med Genet. 2009. PMID: 19880712

31

[National French guidelines for management of infants with cystic fibrosis].

Sermet-Gaudelus I, Couderc L, Vrielynck S, Brouard J, Weiss L, Wizla N, Llerena C, Lebourgeois M, Bailly C, Dirou A, Renouil M, Dalphin ML, Rault G, Munck A, Roussey M; Groupe de travail dépistage de la Fédération des centres de ressources et de compétences de la mucoviscidose; Groupe de travail dépistage de la Fédération des centres de ressources et de compétences de la mucoviscidose. Sermet-Gaudelus I, et al. Among authors: munck a. Arch Pediatr. 2014 Jun;21(6):654-62. doi: 10.1016/j.arcped.2014.03.014. Epub 2014 May 10. Arch Pediatr. 2014. PMID: 24815598 French.

32

[No title available]

[No authors listed] [No authors listed] PMID: 33561099

33

CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders.

Thauvin-Robinet C, Munck A, Huet F, de Becdelièvre A, Jimenez C, Lalau G, Gautier E, Rollet J, Flori J, Nové-Josserand R, Soufir JC, Haloun A, Hubert D, Houssin E, Bellis G, Rault G, David A, Janny L, Chiron R, Rives N, Hairion D, Collignon P, Valeri A, Karsenty G, Rossi A, Audrézet MP, Férec C, Leclerc J, Georges Md, Claustres M, Bienvenu T, Gérard B, Boisseau P, Cabet-Bey F, Cheillan D, Feldmann D, Clavel C, Bieth E, Iron A, Simon-Bouy B, Izard V, Steffann J, Viville S, Costa C, Drouineaud V, Fauque P, Binquet C, Bonithon-Kopp C, Morris MA, Faivre L, Goossens M, Roussey M, Girodon E; collaborating working group on p.Arg117His. Thauvin-Robinet C, et al. Among authors: munck a. J Med Genet. 2013 Apr;50(4):220-7. doi: 10.1136/jmedgenet-2012-101427. Epub 2013 Feb 1. J Med Genet. 2013. PMID: 23378603

34

Nutritional considerations in patients with cystic fibrosis.

Munck A. Munck A. Expert Rev Respir Med. 2010 Feb;4(1):47-56. doi: 10.1586/ers.09.66. Expert Rev Respir Med. 2010. PMID: 20387293 Review.

35

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis.

Munck A. Munck A. Int J Neonatal Screen. 2020 Mar 12;6(1):19. doi: 10.3390/ijns6010019. eCollection 2020 Mar. Int J Neonatal Screen. 2020. PMID: 33073016 Free PMC article. Review.

36

Implementation of the French nationwide cystic fibrosis newborn screening program.

Munck A, Dhondt JL, Sahler C, Roussey M. Munck A, et al. J Pediatr. 2008 Aug;153(2):228-33, 233.e1. doi: 10.1016/j.jpeds.2008.02.028. Epub 2008 Apr 18. J Pediatr. 2008. PMID: 18534227

37

Clinical outcome of cystic fibrosis presenting with or without meconium ileus: a matched cohort study.

Munck A, Gérardin M, Alberti C, Ajzenman C, Lebourgeois M, Aigrain Y, Navarro J. Munck A, et al. J Pediatr Surg. 2006 Sep;41(9):1556-60. doi: 10.1016/j.jpedsurg.2006.05.014. J Pediatr Surg. 2006. PMID: 16952591

38

Recurrent abdominal pain in children with cystic fibrosis: a pilot prospective longitudinal evaluation of characteristics and management.

Munck A, Pesle A, Cunin-Roy C, Gerardin M, Ignace I, Delaisi B, Wood C. Munck A, et al. J Cyst Fibros. 2012 Jan;11(1):46-8. doi: 10.1016/j.jcf.2011.07.010. Epub 2011 Sep 9. J Cyst Fibros. 2012. PMID: 21907638 Free article.

39

Diagnosis of Cystic Fibrosis in Screened Populations.

Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg O, Accurso FJ, Davies JC, Rock MJ, Sanders DB, Wilschanski M, Sermet-Gaudelus I, Blau H, Gartner S, McColley SA. Farrell PM, et al. Among authors: munck a. J Pediatr. 2017 Feb;181S:S33-S44.e2. doi: 10.1016/j.jpeds.2016.09.065. J Pediatr. 2017. PMID: 28129810 Free article.

40

G970R-CFTR Mutation (c.2908G>C) Results Predominantly in a Splicing Defect.

Fidler MC, Buckley A, Sullivan JC, Statia M, Boj SF, Vries RGJ, Munck A, Higgins M, Moretto Zita M, Negulescu P, van Goor F, De Boeck K. Fidler MC, et al. Among authors: munck a. Clin Transl Sci. 2021 Mar;14(2):656-663. doi: 10.1111/cts.12927. Epub 2020 Dec 6. Clin Transl Sci. 2021. PMID: 33278322 Free PMC article. Clinical Trial.

41

Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.

Davies JC, Wainwright CE, Canny GJ, Chilvers MA, Howenstine MS, Munck A, Mainz JG, Rodriguez S, Li H, Yen K, Ordoñez CL, Ahrens R; VX08-770-103 (ENVISION) Study Group. Davies JC, et al. Among authors: munck a. Am J Respir Crit Care Med. 2013 Jun 1;187(11):1219-25. doi: 10.1164/rccm.201301-0153OC. Am J Respir Crit Care Med. 2013. PMID: 23590265 Free PMC article. Clinical Trial.

42

Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.

Feigelson J, Anagnostopoulos C, Poquet M, Pecau Y, Munck A, Navarro J. Feigelson J, et al. Among authors: munck a. Arch Dis Child. 1993 May;68(5):653-7. doi: 10.1136/adc.68.5.653. Arch Dis Child. 1993. PMID: 8280210 Free PMC article.

43

Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.

Munck A, Bourmaud A, Bellon G, Picq P, Farrell PM; DPAM Study Group. Munck A, et al. Pediatr Pulmonol. 2020 Apr;55(4):918-928. doi: 10.1002/ppul.24634. Epub 2020 Jan 9. Pediatr Pulmonol. 2020. PMID: 31916691

44

[The French nationwide cystic fibrosis newborn screening program: strategy and results].

Munck A, Roussey M. Munck A, et al. Arch Pediatr. 2008 Jun;15 Suppl 1:S1-6. doi: 10.1016/S0929-693X(08)73940-X. Arch Pediatr. 2008. PMID: 18822253 French.

45

[Newborn screening for cystic fibrosis in France].

Munck A, Cheillan D, Audrezet MP, Guenet D, Huet F. Munck A, et al. Med Sci (Paris). 2021 May;37(5):491-499. doi: 10.1051/medsci/2021051. Epub 2021 May 18. Med Sci (Paris). 2021. PMID: 34003095 Free article. French.

46

Nutrition and growth in cystic fibrosis.

Hankard R, Munck A, Navarro J. Hankard R, et al. Among authors: munck a. Horm Res. 2002;58 Suppl 1:16-20. doi: 10.1159/000064763. Horm Res. 2002. PMID: 12373008 Review.

47

[Digestive symptoms in cystic fibrosis].

Munck A. Munck A. Arch Pediatr. 2003 Sep;10 Suppl 2:333s-337s. doi: 10.1016/s0929-693x(03)90048-0. Arch Pediatr. 2003. PMID: 14671930 Review. French.

48

Pierre-Audigier C, Ferroni A, Sermet-Gaudelus I, Le Bourgeois M, Offredo C, Vu-Thien H, Fauroux B, Mariani P, Munck A, Bingen E, Guillemot D, Quesne G, Vincent V, Berche P, Gaillard JL. Pierre-Audigier C, et al. Among authors: munck a. J Clin Microbiol. 2005 Jul;43(7):3467-70. doi: 10.1128/JCM.43.7.3467-3470.2005. J Clin Microbiol. 2005. PMID: 16000480 Free PMC article.

49

[Nutritional management of cystic fibrosis in children].

Munck A, Navarro J. Munck A, et al. Arch Pediatr. 2000 Apr;7(4):396-401. doi: 10.1016/S0929-693X(00)88836-3. Arch Pediatr. 2000. PMID: 10793928 French.

50

Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy.

Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N, Czernichow P, Polak M. Rolon MA, et al. Among authors: munck a. Acta Paediatr. 2001 Aug;90(8):860-7. Acta Paediatr. 2001. PMID: 11529531

51

Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization.

Munck A, Bonacorsi S, Mariani-Kurkdjian P, Lebourgeois M, Gérardin M, Brahimi N, Navarro J, Bingen E. Munck A, et al. Pediatr Pulmonol. 2001 Oct;32(4):288-92. doi: 10.1002/ppul.1121. Pediatr Pulmonol. 2001. PMID: 11568989

52

Genetic modifiers of liver disease in cystic fibrosis.

Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M Jr, Rowland M, Salvatore F, Taylor CJ, Wainwright C, Wilschanski M, Zemková D, Hannah WB, Phillips MJ, Corey M, Zielenski J, Dorfman R, Wang Y, Zou F, Silverman LM, Drumm ML, Wright FA, Lange EM, Durie PR, Knowles MR; Gene Modifier Study Group. Bartlett JR, et al. JAMA. 2009 Sep 9;302(10):1076-83. doi: 10.1001/jama.2009.1295. JAMA. 2009. PMID: 19738092 Free PMC article.

53

Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.

De Boeck K, Haarman E, Hull J, Lands LC, Moeller A, Munck A, Riethmüller J, Tiddens H, Volpi S, Leadbetter J, Charlton B, Malfroot A; DPM-CF-204 Study Group. De Boeck K, et al. Among authors: munck a. J Cyst Fibros. 2017 May;16(3):380-387. doi: 10.1016/j.jcf.2017.02.003. Epub 2017 Mar 1. J Cyst Fibros. 2017. PMID: 28258928 Free article. Clinical Trial.

54

[Bronchopulmonary infection in cystic fibrosis].

Munck A, Bingen E. Munck A, et al. Rev Prat. 2003 Jan 15;53(2):145-50. Rev Prat. 2003. PMID: 12664845 Review. French.

55

Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients.

Munck A, Malbezin S, Bloch J, Gerardin M, Lebourgeois M, Derelle J, Bremont F, Sermet I, Munck MR, Navarro J. Munck A, et al. Among authors: munck mr. Eur Respir J. 2004 Mar;23(3):430-4. doi: 10.1183/09031936.04.00052504. Eur Respir J. 2004. PMID: 15065834 Free article.

56

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Castellani C, Cuppens H, Macek M Jr, Cassiman JJ, Kerem E, Durie P, Tullis E, Assael BM, Bombieri C, Brown A, Casals T, Claustres M, Cutting GR, Dequeker E, Dodge J, Doull I, Farrell P, Ferec C, Girodon E, Johannesson M, Kerem B, Knowles M, Munck A, Pignatti PF, Radojkovic D, Rizzotti P, Schwarz M, Stuhrmann M, Tzetis M, Zielenski J, Elborn JS. Castellani C, et al. Among authors: munck a. J Cyst Fibros. 2008 May;7(3):179-96. doi: 10.1016/j.jcf.2008.03.009. J Cyst Fibros. 2008. PMID: 18456578 Free PMC article. Review.

57

European Cystic Fibrosis Society Standards of Care: Best Practice guidelines.

Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, Kashirskaya N, Munck A, Ratjen F, Schwarzenberg SJ, Sermet-Gaudelus I, Southern KW, Taccetti G, Ullrich G, Wolfe S; European Cystic Fibrosis Society. Smyth AR, et al. Among authors: munck a. J Cyst Fibros. 2014 May;13 Suppl 1:S23-42. doi: 10.1016/j.jcf.2014.03.010. J Cyst Fibros. 2014. PMID: 24856775 Free article. Review.

58

Does newborn screening influence the young cystic fibrosis cohort included in national registries?

De Boeck K, Munck A, de Monestrol I, Gulmans V, Lemonnier L, Middleton PG, Wanyama S, Thomas M. De Boeck K, et al. Among authors: munck a. Eur Respir J. 2017 Jan 11;49(1):1600686. doi: 10.1183/13993003.00686-2016. Print 2017 Jan. Eur Respir J. 2017. PMID: 28077474 Free article. No abstract available.

59

In situ management and molecular analysis of candidaemia related to a totally implantable vascular access in a cystic fibrosis patient.

Bonacorsi SP, Munck A, Gerardin M, Doit C, Brahimi N, Navarro J, Bingen E. Bonacorsi SP, et al. Among authors: munck a. J Infect. 1996 Jul;33(1):49-51. doi: 10.1016/s0163-4453(96)92795-4. J Infect. 1996. PMID: 8842996

60

[Mucoviscidosis. Nutritional management].

Munck A, Gérardin M, Navarro J. Munck A, et al. Presse Med. 1997 May 3-10;26(15):721-6. Presse Med. 1997. PMID: 9183375 Review. French. No abstract available.

61

[Liver disease, gastrointestinal complications, nutritional management and feeding disorders in pediatric cystic fibrosis].

Debray D, Mas E, Munck A, Gérardin M, Clouzeau H. Debray D, et al. Among authors: munck a. Arch Pediatr. 2016 Dec;23(12S):12S15-12S20. doi: 10.1016/S0929-693X(17)30058-1. Arch Pediatr. 2016. PMID: 28231889 Review. French.

62

[Digestive and nutritional management of adults with cystic fibrosis].

Marteau P, Munck A, Moreau J, Navarro J. Marteau P, et al. Among authors: munck a. Rev Mal Respir. 2000 Aug;17(3 Pt 2):785-97. Rev Mal Respir. 2000. PMID: 11076388 Review. French.

63

Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process.

Munck A, Delmas D, Audrézet MP, Lemonnier L, Cheillan D, Roussey M. Munck A, et al. J Med Screen. 2018 Mar;25(1):6-12. doi: 10.1177/0969141317692611. Epub 2017 Apr 28. J Med Screen. 2018. PMID: 28454512 Free PMC article.

64

[Energy expenditure: contribution of doubly labelled water].

Aubert R, Munck A, Montagnon B, Foucaud P, Navarro J. Aubert R, et al. Among authors: munck a. Pathol Biol (Paris). 1991 Jun;39(6):640-3. Pathol Biol (Paris). 1991. PMID: 1923601 French. No abstract available.

65

[Nasal transepithelial difference of potential in mucoviscidosis. Clinical application of the measurement].

Maherzi A, Ategbo S, Pharaon I, Munck A, Cezard JP, Foucaud P, Navarro J. Maherzi A, et al. Among authors: munck a. Presse Med. 1995 Mar 4;24(9):437-40. Presse Med. 1995. PMID: 7746816 French.

66

Defining key outcomes to evaluate performance of newborn screening programmes for cystic fibrosis.

Munck A, Southern KW, Castellani C, de Winter-de Groot KM, Gartner S, Kashirskaya N, Linnane B, Mayell SJ, Proesmans M, Sands D, Sommerburg O, Barben J; European CF Society Neonatal Screening Working Group (ECFS NSWG). Munck A, et al. J Cyst Fibros. 2021 Sep;20(5):820-823. doi: 10.1016/j.jcf.2021.02.006. Epub 2021 Feb 23. J Cyst Fibros. 2021. PMID: 33637432 Free article. No abstract available.

67

[Iterative intestinal intussusception and appendiceal mucocele in an infant with mucoviscidosis].

Ekert P, Mougenot JF, de Lagausie P, Gerardin M, Le Bourgeois M, Munck A, Aigrain Y, Navarro J. Ekert P, et al. Among authors: munck a. Arch Pediatr. 1998 Apr;5(4):400-3. doi: 10.1016/s0929-693x(98)80027-4. Arch Pediatr. 1998. PMID: 9759160 French.

68

ECFS best practice guidelines: the 2018 revision.

Castellani C, Duff AJA, Bell SC, Heijerman HGM, Munck A, Ratjen F, Sermet-Gaudelus I, Southern KW, Barben J, Flume PA, Hodková P, Kashirskaya N, Kirszenbaum MN, Madge S, Oxley H, Plant B, Schwarzenberg SJ, Smyth AR, Taccetti G, Wagner TOF, Wolfe SP, Drevinek P. Castellani C, et al. Among authors: munck a. J Cyst Fibros. 2018 Mar;17(2):153-178. doi: 10.1016/j.jcf.2018.02.006. Epub 2018 Mar 3. J Cyst Fibros. 2018. PMID: 29506920 Free article. Review.

69

[Digestive and nutritional management].

Munck A, Navarro J, Debray D, Turck D. Munck A, et al. Arch Pediatr. 2001 Dec;8 Suppl 5:838s-855s. doi: 10.1016/s0929-693x(01)80005-1. Arch Pediatr. 2001. PMID: 11811053 French. No abstract available.

70

The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe.

Barben J, Castellani C, Dankert-Roelse J, Gartner S, Kashirskaya N, Linnane B, Mayell S, Munck A, Sands D, Sommerburg O, Pybus S, Winters V, Southern KW. Barben J, et al. Among authors: munck a. J Cyst Fibros. 2017 Mar;16(2):207-213. doi: 10.1016/j.jcf.2016.12.012. Epub 2016 Dec 30. J Cyst Fibros. 2017. PMID: 28043799 Free article.

71

European best practice guidelines for cystic fibrosis neonatal screening.

Castellani C, Southern KW, Brownlee K, Dankert Roelse J, Duff A, Farrell M, Mehta A, Munck A, Pollitt R, Sermet-Gaudelus I, Wilcken B, Ballmann M, Corbetta C, de Monestrol I, Farrell P, Feilcke M, Férec C, Gartner S, Gaskin K, Hammermann J, Kashirskaya N, Loeber G, Macek M Jr, Mehta G, Reiman A, Rizzotti P, Sammon A, Sands D, Smyth A, Sommerburg O, Torresani T, Travert G, Vernooij A, Elborn S. Castellani C, et al. Among authors: munck a. J Cyst Fibros. 2009 May;8(3):153-73. doi: 10.1016/j.jcf.2009.01.004. Epub 2009 Feb 26. J Cyst Fibros. 2009. PMID: 19246252 Free article.

72

Efficacy response in CF patients treated with ivacaftor: post-hoc analysis.

Konstan MW, Plant BJ, Elborn JS, Rodriguez S, Munck A, Ahrens R, Johnson C. Konstan MW, et al. Among authors: munck a. Pediatr Pulmonol. 2015 May;50(5):447-55. doi: 10.1002/ppul.23173. Epub 2015 Mar 9. Pediatr Pulmonol. 2015. PMID: 25755212 Clinical Trial.

73

CFTR mutations in Turkish and North African cystic fibrosis patients in Europe: implications for screening.

Lakeman P, Gille JJ, Dankert-Roelse JE, Heijerman HG, Munck A, Iron A, Grasemann H, Schuster A, Cornel MC, Ten Kate LP. Lakeman P, et al. Among authors: munck a. Genet Test. 2008 Mar;12(1):25-35. doi: 10.1089/gte.2007.0046. Genet Test. 2008. PMID: 18373402

74

[Cystic fibrosis newborn screening: management issues].

Munck A, Roussey M. Munck A, et al. Arch Pediatr. 2012 May;19 Suppl 1:S30-2. doi: 10.1016/S0929-693X(12)71106-5. Arch Pediatr. 2012. PMID: 22682488 French.

75

A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.

Mayell SJ, Munck A, Craig JV, Sermet I, Brownlee KG, Schwarz MJ, Castellani C, Southern KW; European Cystic Fibrosis Society Neonatal Screening Working Group. Mayell SJ, et al. Among authors: munck a. J Cyst Fibros. 2009 Jan;8(1):71-8. doi: 10.1016/j.jcf.2008.09.005. Epub 2008 Oct 28. J Cyst Fibros. 2009. PMID: 18957277 Free article.

76

[Mucoviscidosis. Antibiotic management].

Le Bourgeois M, Gérardin M, Munck A, Navarro J. Le Bourgeois M, et al. Among authors: munck a. Presse Med. 1997 May 3-10;26(15):727-32. Presse Med. 1997. PMID: 9183376 Review. French. No abstract available.

77

International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome.

Munck A, Alberti C, Colombo C, Kashirskaya N, Ellemunter H, Fotoulaki M, Houwen R, Robberecht E, Boizeau P, Wilschanski M; CF/Pancreas ESPGHAN Working Group and DIOS Study Group. Munck A, et al. J Cyst Fibros. 2016 Jul;15(4):531-9. doi: 10.1016/j.jcf.2016.02.002. Epub 2016 Feb 23. J Cyst Fibros. 2016. PMID: 26927601 Free article.

78

Newborn screening for CF in France: An exemplary national experience.

Audrézet MP, Munck A. Audrézet MP, et al. Among authors: munck a. Arch Pediatr. 2020 Feb;27 Suppl 1:eS35-eS40. doi: 10.1016/S0929-693X(20)30049-X. Arch Pediatr. 2020. PMID: 32172935

79

Inconclusive diagnosis after a positive newborn bloodspot screening result for cystic fibrosis; clarification of the harmonised international definition.

Southern KW, Barben J, Gartner S, Munck A, Castellani C, Mayell SJ, Davies JC, Winters V, Murphy J, Salinas D, McColley SA, Ren CL, Farrell PM. Southern KW, et al. Among authors: munck a. J Cyst Fibros. 2019 Nov;18(6):778-780. doi: 10.1016/j.jcf.2019.04.010. Epub 2019 Apr 24. J Cyst Fibros. 2019. PMID: 31027826 Free article. No abstract available.

80

Standards of care guidance for sweat testing; phase two of the ECFS quality improvement programme.

Cirilli N, Southern KW, Barben J, Vermeulen F, Munck A, Wilschanski M, Nguyen-Khoa T, Aralica M, Simmonds NJ, De Wachter E; ECFS Diagnostic Network Working Group. Cirilli N, et al. Among authors: munck a. J Cyst Fibros. 2022 May;21(3):434-441. doi: 10.1016/j.jcf.2022.01.004. Epub 2022 Jan 19. J Cyst Fibros. 2022. PMID: 35063396

81

Real life practice of sweat testing in Europe.

Cirilli N, Southern KW, Buzzetti R, Barben J, Nährlich L, Munck A, Wilschanski M, De Boeck K, Derichs N; of the ECFS Diagnostic Network Working Group. Cirilli N, et al. Among authors: munck a. J Cyst Fibros. 2017 Sep 27:S1569-1993(17)30881-0. doi: 10.1016/j.jcf.2017.09.002. Online ahead of print. J Cyst Fibros. 2017. PMID: 28964647 Free article.

82

A new highly discriminatory multiplex capillary-based MLVA assay as a tool for the epidemiological survey of Pseudomonas aeruginosa in cystic fibrosis patients.

Sobral D, Mariani-Kurkdjian P, Bingen E, Vu-Thien H, Hormigos K, Lebeau B, Loisy-Hamon F, Munck A, Vergnaud G, Pourcel C. Sobral D, et al. Among authors: munck a. Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2247-56. doi: 10.1007/s10096-012-1562-5. Epub 2012 Feb 11. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22327344

83

Newborn screening programmes including genetic analyses: limits and risks of negative consequences?

Thauvin-Robinet C, Munck A, Roussey M, Huet F, Binquet C, Girodon E. Thauvin-Robinet C, et al. Among authors: munck a. J Epidemiol Community Health. 2010 Nov;64(11):937-8. doi: 10.1136/jech.2009.104331. Epub 2010 Jun 16. J Epidemiol Community Health. 2010. PMID: 20558419 No abstract available.

84

[Gastro-esophageal reflux in pediatrics, an ever-present problem].

Navarro J, Munck A, Foucaud P. Navarro J, et al. Among authors: munck a. Pediatrie. 1988;43(7):585-7. Pediatrie. 1988. PMID: 3200660 French. No abstract available.

85

Penetrance is a critical parameter for assessing the disease liability of CFTR variants.

Boussaroque A, Audrézet MP, Raynal C, Sermet-Gaudelus I, Bienvenu T, Férec C, Bergougnoux A, Lopez M, Scotet V, Munck A, Girodon E. Boussaroque A, et al. Among authors: munck a. J Cyst Fibros. 2020 Nov;19(6):949-954. doi: 10.1016/j.jcf.2020.03.019. Epub 2020 Apr 20. J Cyst Fibros. 2020. PMID: 32327388 Free article.

86

Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.

Ren CL, Borowitz DS, Gonska T, Howenstine MS, Levy H, Massie J, Milla C, Munck A, Southern KW. Ren CL, et al. Among authors: munck a. J Pediatr. 2017 Feb;181S:S45-S51.e1. doi: 10.1016/j.jpeds.2016.09.066. J Pediatr. 2017. PMID: 28129812

87

[Desmoid tumors in an adolescent girl with familial adenomatous polyposis].

Creuzé M, Afchain P, Munck A, Viala J, Bonnard A, Bertrand V. Creuzé M, et al. Among authors: munck a. Arch Pediatr. 2016 Nov;23(11):1141-1145. doi: 10.1016/j.arcped.2016.08.009. Epub 2016 Sep 28. Arch Pediatr. 2016. PMID: 27692552 French.

88

Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).

Barben J, Castellani C, Munck A, Davies JC, de Winter-de Groot KM, Gartner S, Kashirskaya N, Linnane B, Mayell SJ, McColley S, Ooi CY, Proesmans M, Ren CL, Salinas D, Sands D, Sermet-Gaudelus I, Sommerburg O, Southern KW; European CF Society Neonatal Screening Working Group (ECFS NSWG). Barben J, et al. Among authors: munck a. J Cyst Fibros. 2021 Sep;20(5):810-819. doi: 10.1016/j.jcf.2020.11.006. Epub 2020 Nov 27. J Cyst Fibros. 2021. PMID: 33257262 Free article. Review.

89

Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS.

Houwen RH, van der Doef HP, Sermet I, Munck A, Hauser B, Walkowiak J, Robberecht E, Colombo C, Sinaasappel M, Wilschanski M; ESPGHAN Cystic Fibrosis Working Group. Houwen RH, et al. Among authors: munck a. J Pediatr Gastroenterol Nutr. 2010 Jan;50(1):38-42. doi: 10.1097/MPG.0b013e3181a6e01d. J Pediatr Gastroenterol Nutr. 2010. PMID: 19525866

90

[Use of GEE for modeling censored correlated data: application to the study of risk factors for withdrawal of totally implantable vascular access devices in cystic fibrosis].

Bloch J, Chavance M, Lellouch J, Tahri N, Munck A, Malbezin S. Bloch J, et al. Among authors: munck a. Rev Epidemiol Sante Publique. 1999 Dec;47(6):585-91. Rev Epidemiol Sante Publique. 1999. PMID: 10673592 French.

91

[Evaluation of the French nationwide cystic fibrosis newborn screening program].

Munck A, Houssin E, Roussey M. Munck A, et al. Arch Pediatr. 2008 Jun;15(5):741-3. doi: 10.1016/S0929-693X(08)71895-5. Arch Pediatr. 2008. PMID: 18582734 French. No abstract available.

92

Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis.

Jacquemin E, Hermeziu B, Kibleur Y, Friteau I, Mathieu D, Le Coz F, Moyse D, Gérardin M, Jacqz-Aigrain E, Munck A. Jacquemin E, et al. Among authors: munck a. J Clin Pharm Ther. 2009 Oct;34(5):515-22. doi: 10.1111/j.1365-2710.2009.01027.x. J Clin Pharm Ther. 2009. PMID: 19744007 Clinical Trial.

93

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening.

Munck A, Mayell SJ, Winters V, Shawcross A, Derichs N, Parad R, Barben J, Southern KW; ECFS Neonatal Screening Working Group. Munck A, et al. J Cyst Fibros. 2015 Nov;14(6):706-13. doi: 10.1016/j.jcf.2015.01.001. Epub 2015 Jan 24. J Cyst Fibros. 2015. PMID: 25630966 Free article.

94

Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension.

Debray D, Lykavieris P, Gauthier F, Dousset B, Sardet A, Munck A, Laselve H, Bernard O. Debray D, et al. Among authors: munck a. J Hepatol. 1999 Jul;31(1):77-83. doi: 10.1016/s0168-8278(99)80166-4. J Hepatol. 1999. PMID: 10424286

95

[Perspective of use of rhDNase and new therapeutics for cystic fibrosis].

Navarro J, Munck A. Navarro J, et al. Among authors: munck a. Arch Pediatr. 1995 Jul;2(7):682-4. doi: 10.1016/0929-693x(96)81227-9. Arch Pediatr. 1995. PMID: 7663661 Review. French.

96

[Cystic fibrosis: the French neonatal screening organization, preliminary results].

Munck A, Sahler C, Briard M, Vidailhet M, Farriaux JP. Munck A, et al. Arch Pediatr. 2005 Jun;12(6):646-9. doi: 10.1016/j.arcped.2005.04.064. Arch Pediatr. 2005. PMID: 15904757 French. No abstract available.

97

The importance of sweat testing for older siblings of patients with cystic fibrosis identified by newborn screening.

Munck A, Houssin E, Roussey M. Munck A, et al. J Pediatr. 2009 Dec;155(6):928-930.e1. doi: 10.1016/j.jpeds.2009.06.018. J Pediatr. 2009. PMID: 19914431

98

Neonatal screening for cystic fibrosis: comparing the performances of IRT/DNA and IRT/PAP.

Sarles J, Giorgi R, Berthézène P, Munck A, Cheillan D, Dagorn JC, Roussey M. Sarles J, et al. Among authors: munck a. J Cyst Fibros. 2014 Jul;13(4):384-90. doi: 10.1016/j.jcf.2014.01.004. Epub 2014 Feb 7. J Cyst Fibros. 2014. PMID: 24513262 Free article.

99

Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy.

Audrézet MP, Munck A, Scotet V, Claustres M, Roussey M, Delmas D, Férec C, Desgeorges M. Audrézet MP, et al. Among authors: munck a. Genet Med. 2015 Feb;17(2):108-16. doi: 10.1038/gim.2014.113. Epub 2014 Aug 14. Genet Med. 2015. PMID: 25122143 Free article.

100

[French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening].

Sermet-Gaudelus I, Munck A, Rota M, Roussey M, Feldmann D, Nguyen-Khoa T; Groupe de travail "Dépistage néonatal" de la Fédération des centres de ressources et de compétences de la mucoviscidose. Sermet-Gaudelus I, et al. Among authors: munck a. Arch Pediatr. 2010 Sep;17(9):1349-58. doi: 10.1016/j.arcped.2010.06.021. Epub 2010 Aug 16. Arch Pediatr. 2010. PMID: 20719482 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page